Portugal

Infarmed prohibits the export of 52 medicines

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 06/10/2026, 18:16:24 UTC.

Briefings

Infarmed announced a microbe contamination in a Greek factory affecting the supply of quetiapine across the EU. Restrictions on exports were implemented immediately following the discovery, impacting pharmaceutical availability in multiple member states.

Key points

• A microbe contamination was identified in a Greek pharmaceutical factory, directly affecting the supply chain of quetiapine.
• Export restrictions were enacted immediately after the contamination was discovered, impacting EU markets.

Context

This incident represents a critical supply chain disruption in the pharmaceutical sector, specifically targeting a widely prescribed medication in the European Union.

Limitations

The evidence is limited to a single reported event from a specific date. No further details regarding the specific strain of bacteria, the exact number of affected countries, or the timeline of the contamination investigation are provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 23/10/2026, 02:44:37 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigdgytzxs2raxa6rhao5okkrvcnw7aisjrdlc373htdkdc3tecrvm